Convergence launches with $35.4 million

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) spun out Convergence Pharmaceuticals Ltd. (Cambridge, U.K.), which raised $35.4 million in a

Read the full 176 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE